None listed
Conditions
Interventions
Intervention1: Nil: Nil
Control Intervention1: Baseline (Pre-treatment Assessment): Participants serve as their own control. Baseline PBAC, BAT, and quality-of-life scores prior to treatment initiatio
Sponsors
Dr Sreeraj V
Eligibility
Inclusion criteria
Inclusion criteria: 20 healthy volunteer and 100 patients on warfarin or Actorm.
Exclusion criteria
Exclusion criteria: Patients on anticoagulants other than warfarin
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Correlation and agreement between PaperClot-derived estimate/model output and laboratory PT/INR at the same visit, using Pearson correlation and Bland Altman agreement methods.Timepoint: Baseline - Day 0 (simultaneous finger-prick testing and venous blood sampling during the same visit). | — |
Secondary
| Measure | Time frame |
|---|---|
| Diagnostic discrimination performance using ROC analysis.Timepoint: Single time point at the time of testing (same visit). | — |
Countries
India
Contacts
Public ContactDr Sreeraj V
Amala Institute of Medical Sciences,Thrissur,Kerala.
Outcome results
None listed